167 related articles for article (PubMed ID: 24462228)
1. Altered polysomnographic profile in juvenile myoclonic epilepsy.
Krishnan P; Sinha S; Taly AB; Ramachandraiah CT; Rao S; Satishchandra P
Epilepsy Res; 2014 Mar; 108(3):459-67. PubMed ID: 24462228
[TBL] [Abstract][Full Text] [Related]
2. Interrelationship of sleep and juvenile myoclonic epilepsy (JME): a sleep questionnaire-, EEG-, and polysomnography (PSG)-based prospective case-control study.
Ramachandraiah CT; Sinha S; Taly AB; Rao S; Satishchandra P
Epilepsy Behav; 2012 Nov; 25(3):391-6. PubMed ID: 23103316
[TBL] [Abstract][Full Text] [Related]
3. Sleep architecture in patients with Juvenile Myoclonic Epilepsy.
Mekky JF; Elbhrawy SM; Boraey MF; Omar HM
Sleep Med; 2017 Oct; 38():116-121. PubMed ID: 29031745
[TBL] [Abstract][Full Text] [Related]
4. Sleep disturbances in juvenile myoclonic epilepsy: a sleep questionnaire-based study.
Krishnan P; Sinha S; Taly AB; Ramachandraiah CT; Rao S; Satishchandra P
Epilepsy Behav; 2012 Mar; 23(3):305-9. PubMed ID: 22366052
[TBL] [Abstract][Full Text] [Related]
5. Effect of valproate on the sleep microstructure of juvenile myoclonic epilepsy patients - a cross-sectional CAP based study.
Nayak CS; Sinha S; Nagappa M; Kandavel T; Taly AB
Sleep Med; 2016 Jan; 17():129-33. PubMed ID: 26847987
[TBL] [Abstract][Full Text] [Related]
6. Sleep abnormalities in juvenile myoclonic epilepsy-A sleep questionnaire and polysomnography based study.
Roshan S; Puri V; Chaudhry N; Gupta A; Rabi SK
Seizure; 2017 Aug; 50():194-201. PubMed ID: 28704743
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of valproic acid resistant juvenile myoclonic epilepsy.
Fernando-Dongas MC; Radtke RA; VanLandingham KE; Husain AM
Seizure; 2000 Sep; 9(6):385-8. PubMed ID: 10985993
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
Kothare SV; Valencia I; Khurana DS; Hardison H; Melvin JJ; Legido A
Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with lack of response to valproic acid monotherapy in juvenile myoclonic epilepsy.
Jayalakshmi S; Vooturi S; Bana AK; Sailaja S; Somayajula S; Mohandas S
Seizure; 2014 Aug; 23(7):527-32. PubMed ID: 24794160
[TBL] [Abstract][Full Text] [Related]
10. Evolution of juvenile myoclonic epilepsy treated from the outset with sodium valproate.
Calleja S; Salas-Puig J; Ribacoba R; Lahoz CH
Seizure; 2001 Sep; 10(6):424-7. PubMed ID: 11700996
[TBL] [Abstract][Full Text] [Related]
11. Juvenile myoclonic epilepsy and sleep.
Xu L; Guo D; Liu YY; Qiao DD; Ye JY; Xue R
Epilepsy Behav; 2018 Mar; 80():326-330. PubMed ID: 29358100
[TBL] [Abstract][Full Text] [Related]
12. Predictors of seizure control in patients with juvenile myoclonic epilepsy (JME).
Asadi-Pooya AA; Hashemzehi Z; Emami M
Seizure; 2014 Nov; 23(10):889-91. PubMed ID: 25189101
[TBL] [Abstract][Full Text] [Related]
13. The visual scoring of sleep and arousal in infants and children.
Grigg-Damberger M; Gozal D; Marcus CL; Quan SF; Rosen CL; Chervin RD; Wise M; Picchietti DL; Sheldon SH; Iber C
J Clin Sleep Med; 2007 Mar; 3(2):201-40. PubMed ID: 17557427
[TBL] [Abstract][Full Text] [Related]
14. [Juvenile myoclonic epilepsy].
Ercegovac MD; Vojvodić N; SokićDV ; Janković SM; Drulović J; Stojsavljević N; Lević Z
Srp Arh Celok Lek; 1998; 126(9-10):335-44. PubMed ID: 9863404
[TBL] [Abstract][Full Text] [Related]
15. Levetiracetam and Valproate Retention Rate in Juvenile Myoclonic Epilepsy.
Sala-Padró J; Toledo M; Santamarina E; González-Cuevas M; Raspall-Chaure M; Sueiras-Gil M; Quintana M; Salas-Puig X
Clin Neuropharmacol; 2016; 39(6):299-301. PubMed ID: 27438183
[TBL] [Abstract][Full Text] [Related]
16. Electroclinical aspects and therapy of Han patients with juvenile myoclonic epilepsy in northern China.
Wang L; Jiang Z; Chen BB; Wang CT; Wang JX; Bai J; Wang B; Jin L; Zhang WJ; Deng YC; Zhao G; Dang JX; Wang D; Jia SS; Wang TC; Jia FY; Zhang L; Liu YH
Epilepsy Behav; 2016 Sep; 62():204-8. PubMed ID: 27494356
[TBL] [Abstract][Full Text] [Related]
17. Frontal lobe cognitive functions and electroencephalographic features in juvenile myoclonic epilepsy.
Sezikli S; Pulat TA; Tekin B; Ak PD; Keskinkılıç C; Ataklı D
Epilepsy Behav; 2018 Sep; 86():102-107. PubMed ID: 30017834
[TBL] [Abstract][Full Text] [Related]
18. Modulation of epileptiform EEG discharges in juvenile myoclonic epilepsy: an investigation of reflex epileptic traits.
Beniczky S; Guaranha MS; Conradsen I; Singh MB; Rutar V; Lorber B; Braga P; Fressola AB; Inoue Y; Yacubian EM; Wolf P
Epilepsia; 2012 May; 53(5):832-9. PubMed ID: 22462763
[TBL] [Abstract][Full Text] [Related]
19. Comparing sleep profiles between patients with juvenile myoclonic epilepsy and symptomatic partial epilepsy: Sleep questionnaire-based study.
Saraswati N; Nayak C; Sinha S; Nagappa M; Thennarasu K; Taly AB
Epilepsy Behav; 2017 Jan; 66():34-38. PubMed ID: 28012415
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of low-dose valproic acid treatment in patients with juvenile myoclonic epilepsy.
Gürer R; Aydın Ş; Özkara Ç
Seizure; 2019 Aug; 70():43-48. PubMed ID: 31252363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
